Prosecution Insights
Last updated: October 04, 2026

Hyperbio Biological Technology Co. Ltd.

Technology area: Medical Devices & Mechanical Engineering

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Hyperbio Biological Technology Co. Ltd. operates within the Medical Devices & Mechanical Engineering technology area. The portfolio currently manages 2 pending office actions distributed across 2 distinct examiners. This distribution indicates that each examiner is responsible for an action. The workload is further divided among distinct art units, matching the count of examiners.

WELCH, WILLOW GRACE is identified as the busiest examiner, holding 1 busiest examiner pending action. This is part of the pending office actions for the company. The presence of distinct art units suggests the portfolio covers diverse technical sub-sectors within the broader Medical Devices & Mechanical Engineering field. With distinct examiners and art units, the actions are being processed in separate technical environments.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WELCH, WILLOW GRACE 1 55.6% +46.6%
SCHAETZLE, KENNEDY 1 83.8% +8.1%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18701780 METHOD AND APPARATUS FOR ANALYZING HIGH-FREQUENCY QRS-COMPLEX DATA SCHAETZLE, KENNEDY 155d overdue
18872866 EXERCISE ELECTROCARDIOGRAM DATA ANALYSIS METHOD AND APPARATUS, COMPUTER DEVICE AND STORAGE MEDIUM WELCH, WILLOW GRACE —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18872866 EXERCISE ELECTROCARDIOGRAM DATA ANALYSIS METHOD AND APPARATUS, COMPUTER DEVICE AND STORAGE MEDIUM WELCH, WILLOW GRACE —

Top Art Units

Art UnitApps
3792 1
3796 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18872866 EXERCISE ELECTROCARDIOGRAM DATA ANALYSIS METHOD AND APPARATUS, COMPUTER DEVICE AND STORAGE MEDIUM WELCH, WILLOW GRACE 3792 §101§102§103§112 Non-Final OA — Pending Dec 09, 2024
18701780 METHOD AND APPARATUS FOR ANALYZING HIGH-FREQUENCY QRS-COMPLEX DATA SCHAETZLE, KENNEDY 3796 §101§103 Non-Final OA 155d overdue Pending Apr 16, 2024

Managing Hyperbio Biological Technology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month